We just passed a major milestone. No, I’m not talking about the 50th anniversary of the Apollo 11 moon landing (although that is certainly worthy of recognition). But while we’re on the subject, it would be remiss of me to… Read More
Nathan Slaughter, Chief Investment Strategist of The Daily Paycheck and High-Yield Investing, has developed a long and successful track record over the years by finding profitable investments no matter where they hide. Nathan's previous experience includes a long tenure at AXA/Equitable Advisors, one of the world's largest financial planning firms. He also honed his research skills at Morgan Keegan, where he managed millions in portfolio assets and performed consultative retirement planning services. To reach more investors, Nathan switched gears in 2004 and began writing full-time. He has since published hundreds of articles for a variety of prominent online and print publications. Nathan has interviewed industry insiders like Paul Weisbruch and CEOs like Tom Evans of Bankrate.com, and has been quoted in the Los Angeles Times for his expertise on economic moats. Nathan's educational background includes NASD Series 6, 7, 63, & 65 certifications, as well as a degree in Finance/Investment Management from Sam M. Walton School of Business, where he received a full academic scholarship. When not following the market, Nathan enjoys watching his favorite baseball team, the Cubs, and camping and fishing with his family.
Analyst Articles
Our first foray into the world of medical and recreational cannabis over at Fast-Track Millionaire remains the industry leader. It was the first among the industry players to secure a large and lucrative partnership deal — in the form of a multi-billion-dollar link with a well-known maker of beers, wines and spirits. It was also the first to buy a large U.S.-based competitor, although the deal is designed not to take place until the U.S. legalizes marijuana on a federal level. In many ways, our first cannabis stock pick has set the standard in the budding industry. But other industry… Read More
Our first foray into the world of medical and recreational cannabis over at Fast-Track Millionaire remains the industry leader. It was the first among the industry players to secure a large and lucrative partnership deal — in the form of a multi-billion-dollar link with a well-known maker of beers, wines and spirits. It was also the first to buy a large U.S.-based competitor, although the deal is designed not to take place until the U.S. legalizes marijuana on a federal level. In many ways, our first cannabis stock pick has set the standard in the budding industry. But other industry players have been following suit. And my Fast-Track Millionaire readers and I have been paying very close attention, looking for what could be tomorrow’s household names in Big Cannabis. —Recommended Link— This Is The Story To Watch In 2019 I’ve found the perfect marijuana business. And it’s not a dispensary, a lab, or a grower. Instead, it provides the one thing each of these businesses need. Something they pay a 400% premium to get access to. And something that retains its value no matter what happens with marijuana laws. More importantly for you, this company… Read More
Some investors may be concerned about buying stocks when the S&P 500 is up double-digits in less than six months. That’s understandable. As I write this, the S&P 500 index has rallied 16.2%, while the market is up 49% over the past five years and 217% over the past decade. But rather than adopt an overly defensive posture, I’ve been telling my Fast-Track Millionaire readers something different… You see, I think the antidote is to invest in rapid-growth industries — places where future profits are likely to outgrow the market by a wide margin. After all, if we can identify… Read More
Some investors may be concerned about buying stocks when the S&P 500 is up double-digits in less than six months. That’s understandable. As I write this, the S&P 500 index has rallied 16.2%, while the market is up 49% over the past five years and 217% over the past decade. But rather than adopt an overly defensive posture, I’ve been telling my Fast-Track Millionaire readers something different… You see, I think the antidote is to invest in rapid-growth industries — places where future profits are likely to outgrow the market by a wide margin. After all, if we can identify the companies delivering the kind of growth I’m talking about — it won’t matter what the rest of the market is doing… the shares of these companies will be positioned to keep delivering. This explains the recent strength in tech, for example. And while there’s plenty of growth in that sector — and you should be paying close attention to it (as we do over at Fast-Track Millionaire)… I’m not here to talk about tech today. Instead, I’d like to touch on another growth industry — where the action has largely been more muted — the fledgling cannabis sector. —Recommended… Read More
Shares of genetic testing company Myriad Genetics (Nasdaq: MYGN) bucked the overall market, rallying 7% in the last hour of trading. The reason: news that the company resolved an issue with the government regarding Medicare billing for the Company’s hereditary cancer testing from 2014 to… Read More
Your Favorite Stocks Scored
Below you’ll find the Maximum Profit scores for the stocks you requested in response to my invitation last week. Once again, I would just like to say thank you to each of you who participated. Now, before we get into the details,… Read More
The S&P 500 Index and Dow Jones Industrial Average are at all-time highs. The same is true for the NASDAQ 100 Index and many other market averages. But some important averages remain well below their all-time highs. Small-cap and mid-cap stocks are well below their all-time highs. For example, if we take a look at the S&P 600 – a small-cap benchmark index – we see it ended last week more than 13% below its August 2018 high. —Recommended Link— Secret “Paycheck Program” Just Discovered… It’s delivering up to 30 checks each year… Checks for… Read More
The S&P 500 Index and Dow Jones Industrial Average are at all-time highs. The same is true for the NASDAQ 100 Index and many other market averages. But some important averages remain well below their all-time highs. Small-cap and mid-cap stocks are well below their all-time highs. For example, if we take a look at the S&P 600 – a small-cap benchmark index – we see it ended last week more than 13% below its August 2018 high. —Recommended Link— Secret “Paycheck Program” Just Discovered… It’s delivering up to 30 checks each year… Checks for $29,799… $62,046… and even up to $225,326 are being raked in using this program. If you’re looking for reliable cash, you need to act right now. This is instantly valuable, so don’t miss out. Click here for the “Paycheck Program” details. The mid-cap S&P 400 (below) is almost 5% below its August high. These indexes demonstrate that the strength in this year’s stock market rally has been driven by large-cap stocks. That can easily be explained by the “TINA” thesis; in fact, pension fund managers and other institutional investors have been citing TINA as… Read More
10 Rare Bargain Stocks I’ve Got My Eye On…
With U.S. stocks hitting record highs, investors face a question of where to invest. True, that’s always THE question — but this market isn’t an ordinary one. Expectations for monetary easing have largely been behind the recent market strength (up nearly 10% since the beginning of June). That’s unusual for a market trading at all-time highs, but these expectations have been all but confirmed after Congressional testimony last week from Federal Reserve Chairman Jerome Powell. While investors await the next earnings cycle (which gets underway this week) for more clues about the direction of profits and the economy, Chairman Powell’s… Read More
With U.S. stocks hitting record highs, investors face a question of where to invest. True, that’s always THE question — but this market isn’t an ordinary one. Expectations for monetary easing have largely been behind the recent market strength (up nearly 10% since the beginning of June). That’s unusual for a market trading at all-time highs, but these expectations have been all but confirmed after Congressional testimony last week from Federal Reserve Chairman Jerome Powell. While investors await the next earnings cycle (which gets underway this week) for more clues about the direction of profits and the economy, Chairman Powell’s words are the basis of their near-term bullishness. But stocks have gotten expensive, and many growth stocks — the ones we invest in over at Fast-Track Millionaire — look reasonable only if their fast growth remains intact. In these conditions, it would be wise to also consider somewhat slower-growing and/or better-valued stocks. If you agree, then this screen is for you… —Recommended Link— How to collect checks for $1,278. $3,225… and even $8,760 Plenty of ordinary Americans are collecting from this “long lost” program. Backed by $1.75 billion in cash and the full authority of… Read More
Our cancer-focused biotech Seattle Genetics (Nasdaq: SGEN) is up more than 15% this morning. The company’s surprise revenue beat is the main reason. Tuesday after the market closed, SGEN released second-quarter results that showed as much as $159 million in revenue brought in by… Read More
The market’s comeback this year is one for the record books: The S&P 500 closed the best first half of a year since 1997. Not too many analysts predicted such a big rally — but then, not too many thought the U.S. Federal Reserve… Read More
An Update On My 2 Favorite Chinese Stocks…
We need to talk about China… #-ad_banner-#And no, I’m not referring to the ongoing trade spat with the country. While that is important and it will be touched on, that is something you can read about anywhere. I want to talk about the country’s importance in the broader global economy, its impact on our portfolio over at Top Stock Advisor, and specifically our direct exposure through two holdings: Alibaba (NYSE: BABA) and Tencent (OTC: TCEHY). Before we dive into our holdings, let’s take a step back and look at the bigger landscape of the country… Massive Size = Massive Opportunity… Read More
We need to talk about China… #-ad_banner-#And no, I’m not referring to the ongoing trade spat with the country. While that is important and it will be touched on, that is something you can read about anywhere. I want to talk about the country’s importance in the broader global economy, its impact on our portfolio over at Top Stock Advisor, and specifically our direct exposure through two holdings: Alibaba (NYSE: BABA) and Tencent (OTC: TCEHY). Before we dive into our holdings, let’s take a step back and look at the bigger landscape of the country… Massive Size = Massive Opportunity In terms of land mass, China and the United States are close in size. However, China boasts nearly 1.4 billion people, which dwarfs the roughly 325 million folks in America. Its economy, as measured by Gross Domestic Product (GDP), sits at $13.6 trillion, which is second only to the United States’ $20.6 trillion. China and the United States trade more goods — nearly $700 billion last year — than any other two countries in the world. But let’s go back to the country’s population… 1.4 billion citizens. That is a lot of people. And a key reason why nearly… Read More